These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29183158)

  • 1. Critical Roles of Glutaredoxin in Brain Cells-Implications for Parkinson's Disease.
    Gorelenkova Miller O; Mieyal JJ
    Antioxid Redox Signal; 2019 Apr; 30(10):1352-1368. PubMed ID: 29183158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
    Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
    Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease.
    Johnson WM; Golczak M; Choe K; Curran PL; Miller OG; Yao C; Wang W; Lin J; Milkovic NM; Ray A; Ravindranath V; Zhu X; Wilson MA; Wilson-Delfosse AL; Chen SG; Mieyal JJ
    Biochemistry; 2016 Aug; 55(32):4519-32. PubMed ID: 26894491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice.
    Verma A; Ray A; Bapat D; Diwakar L; Kommaddi RP; Schneider BL; Hirsch EC; Ravindranath V
    Mov Disord; 2020 Oct; 35(10):1843-1853. PubMed ID: 32618039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of glutaredoxin 1/DJ-1/HSP70 signaling in renal tubular epithelial cells injury induced by ischemia.
    Yin J; Xu R; Wei J; Zhang S
    Life Sci; 2019 Apr; 223():88-94. PubMed ID: 30858124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.
    Rodriguez-Rocha H; Garcia Garcia A; Zavala-Flores L; Li S; Madayiputhiya N; Franco R
    Antioxid Redox Signal; 2012 Dec; 17(12):1676-93. PubMed ID: 22816731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaredoxin-1 Silencing Induces Cell Senescence via p53/p21/p16 Signaling Axis.
    Yang F; Yi M; Liu Y; Wang Q; Hu Y; Deng H
    J Proteome Res; 2018 Mar; 17(3):1091-1100. PubMed ID: 29356545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases.
    Saeed U; Durgadoss L; Valli RK; Joshi DC; Joshi PG; Ravindranath V
    PLoS One; 2008 Jun; 3(6):e2459. PubMed ID: 18560520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death.
    Arodin L; Miranda-Vizuete A; Swoboda P; Fernandes AP
    Free Radic Biol Med; 2014 Aug; 73():328-36. PubMed ID: 24863694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of glutaredoxin 1 and glutaredoxin 2 double knockout on lens epithelial cell function.
    Zhang J; Yu Y; Dang T; Lal K; Wu H
    Exp Eye Res; 2023 Aug; 233():109521. PubMed ID: 37277068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
    Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
    J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxin.
    Johnson WM; Wilson-Delfosse AL; Chen SG; Mieyal JJ
    Ther Targets Neurol Dis; 2015; 2(2):. PubMed ID: 26097894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells.
    Shelton MD; Distler AM; Kern TS; Mieyal JJ
    J Biol Chem; 2009 Feb; 284(8):4760-6. PubMed ID: 19074435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaredoxin 1 protects lens epithelial cells from epithelial-mesenchymal transition by preventing casein kinase 1α S-glutathionylation during posterior capsular opacification.
    Li C; Chen X; Zhang S; Liang C; Ma X; Zhang R; Yan H
    Redox Biol; 2023 Jun; 62():102676. PubMed ID: 36989576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.